Work on Proof of Concept trial for CB-03-01 in alopecia continues. It is target to be completed in 2015
POC/preclinical -> Phase I (safety) -> Phase IIa (safety & efficacy) -> Phase IIb (dose ranging) -> Phase III (large scale safety) -> approval.
Can anyone clarify the approval process for me?
Comment